Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Combination Products Office Meeting 100% Of Review Goals At Nine Months

This article was originally published in The Gray Sheet

Executive Summary

FDA's Office of Combination Products coding system and intercenter consultations database are providing the agency with a first look at OCP's early performance on reviews involving more than one center

You may also be interested in...



AdvaMed Cautions FDA Against Rush To “Primary Mode of Action” Rule

FDA should issue draft guidance defining "primary mode of action" before moving forward with rulemaking to codify the term, according to AdvaMed

AdvaMed Cautions FDA Against Rush To “Primary Mode of Action” Rule

FDA should issue draft guidance defining "primary mode of action" before moving forward with rulemaking to codify the term, according to AdvaMed

Primary Mode Of Action Definition Assessment In Progress – FDA

Stakeholders will have an opportunity to comment on FDA's planned interpretation of "primary mode of action," according to agency officials

UsernamePublicRestriction

Register

OM004514

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel